Wednesday, 22 May 2013

Argentina Pharmaceuticals and Healthcare Report Q3 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Argentina Pharmaceuticals and Healthcare Report Q3 2013
May 22nd 2013, 00:00

BMI View: High inflation has undermined foreign drugmakers'' profitability in Argentina''s pharmaceuticalmarket. The potential currency devaluation will further erode the returns of foreign investment.Nevertheless, some multinationals continue to invest in the country, as its market size, relatively welldevelopedlocal manufacturing force and its strategic location mean Argentina remains an appealingprospect..Headline Expenditure Projections:Pharmaceuticals: ARS39.4bn (US$8.7bn) in 2012 to ARS49.4bn (US$8.9bn) in 2013; +25.3% in localcurrency terms and 2.7% in US dollar terms. The forecast figures remain the same as in Q213....

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment